JNJ vs MYSEW · P/E 17, rev $49.37B vs rev $436
Johnson & Johnson (JNJ) versus Myseum, Inc. (MYSEW) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Myseum, Inc. (MYSEW) common stock listed on NASDAQ.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported MYSEW revenue for 2024-12-31 was $436. Net income was -$5.0M. Revenue was down 35.1% from 2023-12-31 to 2024-12-31. MYSEW currently screens at market cap $0.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. MYSEW currently screens at market cap $0.
Not investment advice. Open the JNJ and MYSEW stock pages for the full models.
Not investment advice.